Affinity Asset Advisors’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.77M | Buy |
603,479
+58,117
| +11% | +$651K | 0.92% | 31 |
|
|
2025
Q1 | $5.6M | Buy |
545,362
+176,664
| +48% | +$1.81M | 0.53% | 29 |
|
|
2024
Q4 | $7.15M | Buy |
368,698
+18,862
| +5% | +$366K | 0.96% | 27 |
|
|
2024
Q3 | $8.57M | Buy |
349,836
+343,796
| +5,692% | +$8.43M | 1.17% | 23 |
|
|
2024
Q2 | $278K | Buy |
+6,040
| New | +$278K | 0.03% | 81 |
|